PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,177 | +1.7% | 19,247 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $116,198 | +37.0% | 18,562 | +4.4% | 0.00% | 0.0% |
| Q1 2023 | $84,787 | -44.1% | 17,775 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $151,563 | -27.1% | 17,421 | -0.4% | 0.00% | -50.0% |
| Q3 2022 | $208,000 | -15.4% | 17,485 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $246,000 | -9.2% | 17,237 | +32.4% | 0.00% | +100.0% |
| Q1 2022 | $271,000 | -15.8% | 13,023 | -6.6% | 0.00% | -50.0% |
| Q4 2021 | $322,000 | -24.8% | 13,939 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $428,000 | -14.7% | 14,357 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $502,000 | +91.6% | 14,698 | +84.6% | 0.00% | +100.0% |
| Q1 2021 | $262,000 | -46.3% | 7,963 | +0.3% | 0.00% | -50.0% |
| Q4 2020 | $488,000 | – | 7,941 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |